← Back to Search

Wearable Sensor Monitoring for Post-Surgical Sports Rehabilitation

N/A
Recruiting
Led By James Voos, MD
Research Sponsored by University Hospitals Cleveland Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months, 9 months, 12 months (once for healthy individuals)
Awards & highlights

Study Summary

This trialwill use a wearable sensor to measure muscle oxygen levels in athletes after ACL or hip surgery. It'll help doctors measure how well they can return to playing sports.

Who is the study for?
This trial is for healthy individuals aged 14 to 22 who are recovering from ACL or hip arthroscopic surgery. It's not suitable for those under 14, over 22, non-English speakers, or pregnant individuals.Check my eligibility
What is being tested?
The study tests how well a Moxy wearable sensor can track muscle oxygen levels during rehabilitation from lower extremity surgeries. The goal is to improve return-to-play protocols by comparing the operated limb with the non-operated one.See study design
What are the potential side effects?
Since this trial involves physical therapy and monitoring rather than drugs, side effects may include typical post-exercise soreness or discomfort related to the recovery process after surgery.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months, 9 months, 12 months (once for healthy individuals)
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months, 9 months, 12 months (once for healthy individuals) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in O2 Saturation levels as measured by Moxy Sensor device
Changes in hemoglobin levels as measured by Moxy Sensor device

Trial Design

2Treatment groups
Experimental Treatment
Group I: Surgical PatientsExperimental Treatment2 Interventions
Patients who have undergone arthroscopic ACL surgery or arthroscopic hip surgery and are undergoing physical therapy for return to sport
Group II: Healthy IndividualsExperimental Treatment2 Interventions
Healthy control patients with no history of knee or hip surgery for comparison of baseline values
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Physical Therapy
2020
Completed Phase 4
~1460

Find a Location

Who is running the clinical trial?

University Hospitals Cleveland Medical CenterLead Sponsor
318 Previous Clinical Trials
339,859 Total Patients Enrolled
James Voos, MDPrincipal InvestigatorUniversity Hospitals Cleveland Medical Center
Sunita Mengers, MDStudy DirectorUniversity Hospitals Cleveland Medical Center

Media Library

Surgical Patients Clinical Trial Eligibility Overview. Trial Name: NCT05488054 — N/A
Hip Injury Research Study Groups: Surgical Patients, Healthy Individuals
Hip Injury Clinical Trial 2023: Surgical Patients Highlights & Side Effects. Trial Name: NCT05488054 — N/A
Surgical Patients 2023 Treatment Timeline for Medical Study. Trial Name: NCT05488054 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

To whom does this scientific research offer participation?

"This medical research is gathering 100 people aged 14-22 with hip injury who meet the criteria of having an ACL tear needing surgical care, not previously had arthroscopic knee or hip surgery, and are healthy."

Answered by AI

How many participants have been included in this research endeavor?

"Affirmative. Per clinicaltrials.gov's records, this medical trial opened for enrolment on August 8th 2022 and is actively recruiting patients from 2 different locations with the goal of obtaining a total sample size of 100 participants."

Answered by AI

Is this medical research open to individuals below the age of forty?

"This clinical research is open to candidates between the ages of 14 and 22."

Answered by AI

Are new participants being solicited for this research project?

"Evidenced by the clinicaltrials.gov website, this medical trial is actively seeking candidates for participation. The initial post date was August 8th 2022 and it has been updated most recently on November 11th 2022."

Answered by AI
~89 spots leftby Jun 2025